Decipher by Veracyte

03/19/2026

Stop by! by Veracyte, Inc. is at the 90th Annual Meeting of the Southeastern Section of AUA (SESAUA) in Río Grande, Puerto Rico. Visit our booth today or tomorrow to learn how we’re helping transform care!

03/13/2026

Swing by! by Veracyte is at the 11th Annual Best of Radiation Oncology 2026 conference in New York. Visit our booth to learn how by Veracyte can help provide clarity and confidence in treatment planning.

03/07/2026

Swing by! by Veracyte is at the Virginia Urological Society 2026 Annual Meeting in Alexandria, VA. Visit our booth today to learn how we’re helping transform care!

02/27/2026

Stop by! The by Veracyte, Inc. team is at the 15th Annual Winter Cancer Symposium in Carolina, Puerto Rico Catch us today or tomorrow to learn how we're transforming care!

02/27/2026

by Veracyte is at the NARUS 2026 Annual Meeting in Las Vegas, NV. We invite you to visit us today or tomorrow to learn how we're transforming care.

08/20/2025

Curious how the test from Veracyte helps inform prostate cancer care? In this video, a urologic oncologist walks through the Decipher test reports step by step, covering both the biopsy and radical prostatectomy versions. See how the Decipher genomic test can support more personalized treatment planning and better-informed physician-patient conversations for men with . Watch the video here: https://www.youtube.com/watch?v=o-m7H57CJxw&t=87s

08/13/2025

Want to understand how the test is used and interpreted? In this video, a urologic oncologist breaks down the Decipher test reports, walking through each section of both the biopsy and radical prostatectomy versions. Discover how Decipher can provide valuable insights to support more confident, personalized care for men with . Watch the full video here: https://www.youtube.com/watch?v=o-m7H57CJxw&t=87s

07/25/2025

ICYMI: From the Prostate Cancer Patient Voices video series by Cancer Foundation

Watch this impactful conversation between two urologists as they discuss how Decipher Prostate by Veracyte is helping bring clarity and confidence to treatment planning for men with prostate cancer.

One of the physicians shares his own personal diagnosis—and how Decipher testing provided the information he and his doctor needed to make a well-informed treatment decision.

Thank you to the Prostate Cancer Foundation for sharing stories like this that elevate real patient experiences and clinical insight.
Don’t miss it! Link here: https://www.prostatecancerpatientvoices.com/patient-journeys/in-conversation-dr-arnold-bullock-dr-eric-kim

07/21/2025

From the Prostate Cancer Patient Voices series by the : Two urologists discuss how by Veracyte brought clarity and confidence to treatment planning. One shares his personal journey—and how Decipher helped guide informed treatment decisions.
Watch the conversation here: https://www.youtube.com/watch?v=o-m7H57CJxw&t=87s

05/30/2025

05/16/2025

Did you know that by Veracyte is the most validated prostate cancer gene expression test? Our tissue-based test has been validated in more than 85 studies and over 200,000 patients as a highly accurate predictor of metastasis. Visit our website to see how Decipher prostate supports those living with and helps physicians and patients make informed treatment decisions. Click here to read more: https://decipherbio.com/decipher-prostate/patients/decipher-prostate-overview/

03/20/2025

Did you know? According to the Prostate Cancer Foundation, the risk of increases considerably as men age. In fact, about 60% of prostate cancer cases are diagnosed in men over the age of 65. That is why early detection and informed decision-making are crucial. Learn more on prostate cancer risk factors by clicking the link: https://www.pcf.org/patient-resources/family-cancer-risk/prostate-cancer-risk-factors/